SAA
ABBV icon

Southeast Asset Advisors’s AbbVie ABBV Stock Holding History

Southeast Asset Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.4M Hold
21,450
– – 0.55% 24
2026
Q1 		$4.67M Sell
21,450
-1,253
-6% -$278K 0.51% 32
2025
Q4 		$5.19M Sell
22,703
-2,608
-10% -$594K 0.49% 37
2025
Q3 		$5.86M Buy
25,311
+9,782
+63% +$1.99M 0.64% 23
2025
Q2 		$2.88M Buy
15,529
+207
+1% +$38.5K 0.34% 49
2025
Q1 		$3.21M Buy
15,322
+2,339
+18% +$455K 0.39% 40
2024
Q4 		$2.31M Sell
12,983
-414
-3% -$76.1K 0.28% 55
2024
Q3 		$2.65M Buy
13,397
+1
+0% +$187 0.29% 53
2024
Q2 		$2.3M Buy
13,396
+2
+0% +$331 0.28% 55
2024
Q1 		$2.44M Sell
13,394
-399
-3% -$68.8K 0.29% 52
2023
Q4 		$2.14M Buy
13,793
+261
+2% +$38.1K 0.28% 52
2023
Q3 		$2.02M Buy
13,532
+1,302
+11% +$191K 0.28% 46
2023
Q2 		$1.65M Buy
12,230
+1
+0% +$147 0.23% 60
2023
Q1 		$1.95M Buy
12,229
+2,630
+27% +$402K 0.29% 49
2022
Q4 		$1.55M Sell
9,599
-1,383
-13% -$212K 0.25% 55
2022
Q3 		$1.47M Sell
10,982
-1,659
-13% -$238K 0.25% 54
2022
Q2 		$1.94M Sell
12,641
-138
-1% -$21.1K 0.31% 45
2022
Q1 		$2.07M Buy
12,779
+502
+4% +$72.9K 0.28% 49
2021
Q4 		$1.66M Buy
12,277
+28
+0.2% +$3.31K 0.23% 61
2021
Q3 		$1.32M Buy
12,249
+1,882
+18% +$215K 0.22% 70
2021
Q2 		$1.17M Buy
10,367
+7,804
+304% +$879K 0.19% 71
2021
Q1 		$277K Buy
2,563
+444
+21% +$47.5K 0.05% 115
2020
Q4 		$227K Buy
+2,119
New +$204K 0.05% 123

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Southeast Asset Advisors's ABBV Position: Q2 2026 in Review

Southeast Asset Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 21,450 shares worth $5.4M. The position accounts for 0.55% of the portfolio, ranked #24.

Southeast Asset Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.86M in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Southeast Asset Advisors held 21,450 shares of AbbVie worth $5.4M as of Q2 2026.
  • Southeast Asset Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.55% of Southeast Asset Advisors's portfolio in Q2 2026, its #24 holding.
  • Southeast Asset Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Southeast Asset Advisors's AbbVie position peaked at $5.86M in Q3 2025.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Southeast Asset Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.